DnaJ热休克蛋白家族成员C9在肺腺癌中的表达及预后价值

Expression of DnaJ heat shock protein family member C9 in lung adenocarcinoma and its value in prognosis

  • 摘要:
    目的 探讨DnaJ热休克蛋白家族成员C9(DNAJC9)在肺腺癌(LUAD)组织中的表达、预后、甲基化情况及与肿瘤免疫浸润的关系。
    方法 利用肿瘤基因组计划(TCGA)中LUAD的表达及临床数据分析DNAJC9的差异表达及预后价值。采用免疫组化法检测40例LUAD患者的癌组织及配对正常组织DNAJC9的蛋白表达; 利用UALCAN数据库及TCGA Wanderer数据库对DNAJC9启动子区域甲基化位点进行分析; 利用TIMER数据库和单样本基因集富集分析(ssGSEA)对DNAJC9表达与LUAD免疫浸润水平的关系进行分析; 根据String数据库分析与DNAJC9相互作用的蛋白,利用FUNRICH富集分析工具对这些基因进行功能富集分析。
    结果 DNAJC9在LUAD组织中的表达水平高于正常组织,差异有统计学意义(P < 0.01)。免疫组化法显示, DNAJC9蛋白在LUAD组织中的表达率为80.0%(32/40), 高于癌旁组织的45.0%(18/40), 差异有统计学意义(P < 0.05)。高表达患者的总生存率、无疾病生存率和无进展生存率均低于低表达者,差异有统计学意义(P < 0.05)。DNAJC9的表达与是否存在TP53突变显著相关(P < 0.05)。DNAJC9基因启动子区域甲基化水平在肿瘤组织中低于正常组织,且和该基因序列表达相关的甲基化位点与其表达水平呈负相关(P < 0.05)。DNAJC9表达与LUAD免疫细胞浸润水平相关。蛋白相互作用网络分析发现,微小染色体维持复合物成分6(MCM6)、核糖核苷酸还原酶催化亚基M1(RRM1)、核自身抗原精子蛋白(NASP)、皮瓣结构特异性内切酶(FEN1)、脱氧尿苷三磷酸酶(DUT)、复制因子C亚基4(RFC4)、序列相似的家族149成员B1 (FAM149B1)、MutS同源2(MSH2)、染色体的结构维持2(SMC2)、小染色体维持复合体成分2 (MCM2)等蛋白与DNAJC9密切相关。富集分析显示,这些基因参与DNA合成、G2/M检查点等信号通路及多种致癌过程。
    结论 DNAJC9的低甲基化水平使DNAJC9在LUAD组织中呈高表达,其高表达提示预后不良,与免疫细胞的浸润相关。

     

    Abstract:
    Objective To investigate the expression of DnaJ heat shock protein family member C9(DNAJC9), methylation, prognosis in lung adenocarcinoma (LUAD) and its relation with immune invasion.
    Methods The expression and clinical data of LUAD in Cancer Genome Atlas (TCGA) were used to analyze the differential expression of DNAJC9 and its prognostic value. Immunohistochemical method was used to detect the expression of DNAJC9 protein in cancer tissues and adjacent normal tissues of 40 LUAD patients. The methylation sites of DNAJC9 promoter region were analyzed using UALCAN and TCGA Wanderer databases. The correlation between DNAJC9 expression and the level of LUAD immune cell infiltration was analyzed by TIMER database and single sample Gene Set Enrichment Analysis (ssGSEA). The proteins interacting with DNAJC9 were analyzed by String database. Finally, FUNRICH enrichment analysis tool was used for functional enrichment analysis of these genes.
    Results The expression of DNAJC9 in LUAD tissues was significantly higher than that in normal tissues (P < 0.01). Immunohistochemistry showed that the expression rate of DNAJC9 protein in LUAD tissues was 80.0%(32/40), which was higher than 45.0% (18/40) in para-cancer tissues(P < 0.05). The overall survival rate, disease-free survival rate and progression-free survival rate of patients with high expression of DNAJC9 were significantly lower than those with low expressions (P < 0.05). The expression of DNAJC9 was significantly correlated with the presence of TP53 mutation (P < 0.05). The methylation level of the promoter region of DNAJC9 gene in tumor tissues was lower than that in normal tissues (P < 0.05), and the methylation sites associated with the expression of the gene sequence were negatively correlated with their expression level(P < 0.05). The expression of DNAJC9 was correlated with the immune infiltration level. Protein interaction network analysis showed that Minichromosome Maintenance Complex Component 6 (MCM6), Ribonucleotide Reductase Catalytic Subunit M1(RRM1), Nuclear Autoantigenic Sperm Protein(NASP), Flap Structure-Specific Endonuclease 1(FEN1), Deoxyuridine Triphosphatase(DUT), Replication Factor C Subunit 4(RFC4), Family With Sequence Similarity 149 Member B1(FAM149B1), MutS Homolog 2(MSH2), Structural Maintenance Of Chromosomes 2(SMC2), Minichromosome Maintenance Complex Component 2(MCM2) proteins had significant interactions with DNAJC9. Pathway enrichment analysis showed that these genes were involved in DNA synthesis, G2/M checkpoint signaling and various carcinogenic processes.
    Conclusion The hypommethylation level of DNAJC9 leads to high expression of DNAJC9 in LUAD tissues. Its high expression is an unfavorable prognostic factor of LUAD and is associated with immune cell invasion.

     

/

返回文章
返回